Cargando…

Prognostic significance of Epstein-Barr virus infection in gastric cancer: a meta-analysis

BACKGROUND: The prognostic significance of Epstein-Barr virus (EBV) infection in gastric cancer (GC) remains unclear. Recently, a number of studies have investigated the association between EBV infection and the prognosis of GC with controversial results. We therefore conducted a meta-analysis to as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xuechao, Liu, Jianjun, Qiu, Haibo, Kong, Pengfei, Chen, Shangxiang, Li, Wei, Zhan, Youqing, Li, Yuanfang, Chen, Yingbo, Zhou, Zhiwei, Xu, Dazhi, Sun, Xiaowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619309/ https://www.ncbi.nlm.nih.gov/pubmed/26498209 http://dx.doi.org/10.1186/s12885-015-1813-9

Ejemplares similares

Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer
por: Liu, Xuechao, et al.
Publicado: (2016)

A Novel Prognostic Score, Based on Preoperative Nutritional Status, Predicts Outcomes of Patients after Curative Resection for Gastric Cancer
por: Liu, Xuechao, et al.
Publicado: (2016)

Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection
por: Liu, Xuechao, et al.
Publicado: (2016)

Impact of systemic inflammation on gastric cancer outcomes
por: Liu, Xuechao, et al.
Publicado: (2017)

Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I–II gastric cancer
por: Sun, Xiaowei, et al.
Publicado: (2016)

Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer
por: Liu, Xuechao, et al.
Publicado: (2015)

Preoperative Nutritional Deficiency Is a Useful Predictor of Postoperative Outcome in Patients Undergoing Curative Resection for Gastric Cancer
por: Liu, Xuechao, et al.
Publicado: (2016)

Nomogram based on systemic inflammatory response markers predicting the survival of patients with resectable gastric cancer after D2 gastrectomy
por: Liu, Jianjun, et al.
Publicado: (2016)

Prognostic value of pretreatment albumin–globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection
por: Liu, Jianjun, et al.
Publicado: (2017)

Development and external validation of a prognostic nomogram for gastric cancer using the national cancer registry
por: Liu, Jianjun, et al.
Publicado: (2016)

Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes
por: Chen, Shangxiang, et al.
Publicado: (2017)

Impact of preoperative anemia on outcomes in patients undergoing curative resection for gastric cancer: a single‐institution retrospective analysis of 2163 Chinese patients
por: Liu, Xuechao, et al.
Publicado: (2018)

A comprehensive analysis comparing the eighth AJCC gastric cancer pathological classification to the seventh, sixth, and fifth editions
por: Seeruttun, Sharvesh Raj, et al.
Publicado: (2017)

Gastric cancer, nutritional status, and outcome
por: Liu, Xuechao, et al.
Publicado: (2017)

Incorporation of Extranodal Metastasis of Gastric Carcinoma into the 7th Edition UICC TNM Staging System
por: Wang, Wei, et al.
Publicado: (2011)

A novel classifier based on three preoperative tumor markers predicting the cancer-specific survival of gastric cancer (CEA, CA19-9 and CA72-4)
por: Guo, Jing, et al.
Publicado: (2017)

Effect of Lymph Node Number on Survival of Patients with Lymph Node-Negative Gastric Cancer according to the 7th Edition UICC TNM System
por: Xu, Dazhi, et al.
Publicado: (2012)

Albumin concentrations plus neutrophil lymphocyte ratios for predicting overall survival after curative resection for gastric cancer
por: Sun, Xiaowei, et al.
Publicado: (2016)

Prognostic Impact of the Signet Ring Cell Type in Node-Negative Gastric Cancer
por: Kong, Pengfei, et al.
Publicado: (2016)

The Effects of Anti-inflammatory Drug Treatment in Gastric Cancer Prevention: an Update of a Meta-analysis
por: Kong, Pengfei, et al.
Publicado: (2016)

A cumulative score based on preoperative fibrinogen and the neutrophil–lymphocyte ratio to predict outcomes in resectable gastric cancer
por: Liu, Xuechao, et al.
Publicado: (2018)

Epstein-Barr Virus in Gastric Carcinoma
por: Nishikawa, Jun, et al.
Publicado: (2014)

Clinical Significance of Epstein-Barr Virus and Helicobacter pylori Infection in Gastric Carcinoma
por: Noh, Jin Hee, et al.
Publicado: (2023)

ASTE1 frameshift mutation triggers the immune response in Epstein-Barr virus-associated gastric cancer
por: Huang, Binhao, et al.
Publicado: (2022)

Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer
por: Liu, Xuechao, et al.
Publicado: (2018)

Vitamin Intake Reduce the Risk of Gastric Cancer: Meta-Analysis and Systematic Review of Randomized and Observational Studies
por: Kong, Pengfei, et al.
Publicado: (2014)

The Methylation Status and Expression of Epstein-Barr Virus Early Genes BARF1 and BHRF1 in Epstein-Barr Virus-Associated Gastric Carcinomas
por: Li, Jing, et al.
Publicado: (2017)

Variations of Epstein-Barr Virus Nuclear Antigen 1 in Epstein-Barr Virus-Associated Gastric Carcinomas from Guangzhou, Southern China
por: Chen, Jian-ning, et al.
Publicado: (2012)

The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer
por: Wei, Xiao-Li, et al.
Publicado: (2021)

Combination of CRP and NLR: a better predictor of postoperative survival in patients with gastric cancer
por: Guo, Jing, et al.
Publicado: (2018)

Expression of Epstein-Barr Virus Gene and Clonality of Infiltrated T Lymphocytes in Epstein-Barr Virus-associated Gastric Carcinoma
por: Lee, Jae Myun, et al.
Publicado: (2011)

The oncogenic role of Epstein–Barr virus‐encoded microRNAs in Epstein–Barr virus‐associated gastric carcinoma
por: Zhang, Jinglin, et al.
Publicado: (2017)

Epstein barr virus encodes miRNAs to assist host immune escape
por: Li, Weiming, et al.
Publicado: (2020)

Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
por: Iizasa, Hisashi, et al.
Publicado: (2012)

Epstein-Barr virus gastric ulcer associated with ruxolitinib
por: Kusano, Yoshiharu, et al.
Publicado: (2016)

Epstein–Barr Virus Infection and Gastric Cancer: A Systematic Review
por: Chen, Xin-Zu, et al.
Publicado: (2015)

Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancer
por: Geng, Qirong, et al.
Publicado: (2017)

Prognostic role of tumor necrosis in patients undergoing curative resection for gastric gastrointestinal stromal tumor: a multicenter analysis of 740 cases in China
por: Liu, Xuechao, et al.
Publicado: (2017)

Characterization of the subcellular localization of Epstein-Barr virus encoded proteins in live cells
por: Cai, Mingsheng, et al.
Publicado: (2017)

Interaction of Epstein-Barr virus genes with human gastric carcinoma transcriptome
por: Zhang, Ruiyuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_86m2fm95rvgb503il6uvfh5nvi